NASDAQ · RDZNW

Roadzen, Inc.

$0.10 -$0.02 (-14.67%) 1D Market open
Charting by TradingView

Key Metrics

$6.71M
Market cap
—
P/E · TTM
$55.02M
Revenue · TTM
−$22.52M
Net income
EPS · TTM $-0.32
Dividend yield —
Free cash flow −$21.28M
Beta · 1Y 1.46
EBITDA · TTM —
Gross margin —

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 24
    From its May 4 high, the share price fell 63%.

    Peak close $0.26 on May 4; trough close $0.10 on Jul 24. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -63%
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 18.6 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • May 12
    The stock moved +31.4% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, May 12
  • Mar 17
    The stock moved +35.3% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Mar 17

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap—
Enterprise value$25.30M
Shares outstanding—
52-wk range$0.05 – $0.32
Avg volume · 20D34.1K
Net cash −$18.59M
Book value / share$-0.42
IndustryInsurance Agents, Brokers & Service
ExchangeNASDAQ
About Roadzen, Inc.
IPO dateSep 21, 2023
Employees459

Roadzen Inc is an insurance technology company on a mission to transform auto insurance powered by AI.

Wolf Grade COMING SOON

—

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E—
P/S0.12
P/FCF—
EV/EBITDA—
EV/Sales0.46
Graham №—

Profitability

Gross —
Operating -41.8%
Net -40.9%
FCF -38.7%
ROE / ROIC 75.9% · 213.4%

Financial Health

Current ratio0.55
Quick ratio0.55
Debt / equity-0.86
Debt / EBITDA —
Net cash −$18.59M
Working capital−$26.05M

Cash Flow · TTM

Operating CF −$20.27M
Capex −$1.01M
Free cash flow −$21.28M
Buybacks —
Dividends paid —
Shareholder yield —

Piotroski F-Score

1 / 9
Weak fundamentals · 1 of 9 signals passing

Altman Z-Score

-7.5
Distress zone (< 1.81) · elevated risk

Graham Number vs Price

—
Requires positive earnings and book value
Fundamentals through 2025-12-31 · computed by TickerWolf from SEC filings